Dr. Agbo is currently a scientist/director at Sunovion Pharmaceuticals Inc., (a subsidiary of Sumitomo Dainippon Pharma Co. Ltd.) a global biopharmaceutical company with focus on the innovative application of science and medicine to help people with serious medical conditions.
He is the clinical pharmacology and modeling and simulation (Pharmacometrics) lead across different therapeutic areas including CNS and Respiratory and supports activities from discovery through registration and post-registration. He has previously held positions as preclinical and Clinical PK/PD scientist, Clinical Pharmacologist and Pharmacometrician at Genzyme biotechnology, IQVIA (Quintiles) and AstraZeneca and worked on both small and large molecules in different therapeutic areas including rare diseases such as cystic fibrosis and oncology.
With his background spanning from Veterinary medicine, Clinical pharmacology, Pharmacokinetics/Pharmacodynamics and deep interest in quantitative aspect of pharmacology (Pharmacometrics), Felix realized the need to become a member of ISoP as a critical path for his career development and networking. Felix joined ACoP in 2009 and has since maintained an active membership. As a member of the International Society of Pharmacometrics (ISoP) he regularly attends annual meetings held mostly in North America (ACoP) and in Europe (PAGE) and sometimes WCoP. With a joint membership of ASCPT and ISoP, Felix continues to enjoy the many benefits provided by the membership which include access to most of the prestigious journals in the field of Pharmacometrics and Clinical Pharmacology. The ISoP annual meetings have become one of the important avenues for him to access innovative and cutting-edge methodologies and applications that are directed towards drug development and model-based drug development.